ambossIconambossIcon

Induced abortion

Last updated: January 27, 2025

CME information and disclosurestoggle arrow icon

To see contributor disclosures related to this article, hover over this reference: [1]

Physicians may earn CME/MOC credit by searching for an answer to a clinical question on our platform, reading content in this article that addresses that question, and completing an evaluation in which they report the question and the impact of what has been learned on clinical practice.

AMBOSS designates this Internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

For answers to questions about AMBOSS CME, including how to redeem CME/MOC credit, see "Tips and Links" at the bottom of this article.

Summarytoggle arrow icon

Induced abortion is the use of interventions to end a pregnancy and remove products of conception from the uterus. Common indications include patient choice, anticipated harm to the pregnant individual, and fetal genetic or anatomical abnormalities. A preabortion evaluation involves confirmation of pregnancy and determination of gestational age, with additional studies as indicated based on patient history and preferences. Uterine evacuation for induced abortion is achieved using the same medications and/or procedures that are used to manage pregnancy loss. A combined regimen of mifepristone and misoprostol is recommended for medication abortion in the first and second trimester of pregnancy. Recommended procedural abortion techniques are uterine aspiration in the first trimester and dilation and evacuation in the second trimester. Postabortion care involves monitoring for complications of induced abortion and providing additional care related to family planning and psychosocial support as indicated.

Definitionstoggle arrow icon

  • Induced abortion: the use of interventions (e.g., medications, procedures) to end a pregnancy
  • Medication abortion: the administration of medications to end a pregnancy [4]
  • Procedural abortion: the physical removal of products of conception from the uterus to end a pregnancy
  • Self-managed abortion: the management of an abortion by the pregnant individual outside of a health care setting [5][6][7]
  • Unsafe abortion: the termination of a pregnancy by an individual lacking necessary skills, in unsafe conditions (e.g., using nonsterile tools), and/or using unsafe methods (e.g., toxins, abdominal trauma) [6][8]

Epidemiologytoggle arrow icon

  • More than 90% of abortions occur before 13 weeks' gestation. [9]
  • Nearly 25% of female individuals will have an abortion by 45 years of age. [10]

Epidemiological data refers to the US, unless otherwise specified.

Preabortion evaluationtoggle arrow icon

Methodstoggle arrow icon

Types of induced abortion [15]
Medication abortion [4][16] Procedural abortion

First trimester [4][6][17]

Second trimester [11]

Prophylactic antibiotics should be provided for all procedural abortions, but are not indicated for medication abortion. [11]

A limited number of facilities in the US provide second-trimester abortions and these are almost always are procedural. [9]

Postabortion caretoggle arrow icon

A follow-up visit is typically unnecessary after an uncomplicated induced abortion, but should be offered to all patients. [4][6][19]

Patients who self-manage abortion may seek medical care to confirm that abortion is complete.

Complicationstoggle arrow icon

Complications are rare, including after self-managed medication abortion in the first-trimester. Risk of complications increases with later abortions and unsafe abortions. [7][22][23]

Induced abortion does not increase the risk of mental health disorders, infertility, or breast cancer. [22]

We list the most important complications. The selection is not exhaustive.

Legal implicationstoggle arrow icon

Related One-Minute Telegramtoggle arrow icon

Interested in the newest medical research, distilled down to just one minute? Sign up for the One-Minute Telegram in “Tips and links” below.

Referencestoggle arrow icon

  1. Upadhyay UD, Coplon L, Atrio JM, with the assistance of M Villalonga and on behalf of the Society of Family Planning Clinical Affairs Committee. Society of Family Planning Committee Statement: Abortion nomenclature. Contraception. 2023; 126: p.110094.doi: 10.1016/j.contraception.2023.110094 . | Open in Read by QxMD
  2. ACOG Guide to Language and Abortion. https://www.acog.org/-/media/project/acog/acogorg/files/pdfs/publications/abortion-language-guide.pdf?rev=6a0fefaa709c402d8c0543b2dfded347&hash=477D24C7829F9412D6CAAF18AC95AEF4. Updated: October 1, 2024. Accessed: November 7, 2024.
  3. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology, Society of Family Planning. ACOG Practice Bulletin No. 225: Medication Abortion Up to 70 Days of Gestation. Obstet Gynecol. 2020; 136 (4): p.e31-e47.doi: 10.1097/aog.0000000000004082 . | Open in Read by QxMD
  4. American College of Obstetricians and Gynecologists. ACOG Committee Statement No. 13: Self-Managed Abortion. Obstet Gynecol. 2024; 144 (6): p.e152-e159.doi: 10.1097/AOG.0000000000005755 . | Open in Read by QxMD
  5. Abortion care guideline. https://www.who.int/publications-detail-redirect/9789240039483. Updated: March 9, 2022. Accessed: June 29, 2022.
  6. $Society of Family Planning Interim Clinical Recommendations: Self-managed abortion.
  7. Ganatra B, Gerdts C, Rossier C, et al. Global, regional, and subregional classification of abortions by safety, 2010–14: estimates from a Bayesian hierarchical model. Lancet. 2017; 390 (10110): p.2372-2381.doi: 10.1016/s0140-6736(17)31794-4 . | Open in Read by QxMD
  8. Ramer S, Nguyen AT, Hollier LM, Rodenhizer J, Warner L, Whiteman MK. Abortion Surveillance — United States, 2022. MMWR Surveillance Summaries. 2024; 73 (7): p.1-28.doi: 10.15585/mmwr.ss7307a1 . | Open in Read by QxMD
  9. Jones RK. An estimate of lifetime incidence of abortion in the United States using the 2021–2022 Abortion Patient Survey. Contraception. 2024; 135: p.110445.doi: 10.1016/j.contraception.2024.110445 . | Open in Read by QxMD
  10. National Academies of Sciences, Engineering, and Medicine. The Safety and Quality of Abortion Care in the United States. National Academies Press ; 2018
  11. ACOG. ACOG Practice Bulletin No. 135: Second-trimester abortion. Obstet Gynecol. 2013; 121 (6): p.1394-1406.doi: 10.1097/01.AOG.0000431056.79334.cc . | Open in Read by QxMD
  12. Orlowski MH, Soares WE, Kerrigan KA, Zerden ML. Management of Postabortion Complications for the Emergency Medicine Clinician. Ann Emerg Med. 2021; 77 (2): p.221-232.doi: 10.1016/j.annemergmed.2020.09.008 . | Open in Read by QxMD
  13. Moss DA, Snyder MJ, Lu L. Options for women with unintended pregnancy. Am Fam Physician. 2015; 91 (8): p.544-9.
  14. Raymond EG, Mark A, Grossman D, et al. Medication abortion with misoprostol-only: A sample protocol. Contraception. 2023; 121: p.109998.doi: 10.1016/j.contraception.2023.109998 . | Open in Read by QxMD
  15. 2024 Clinical Policy Guidelines for Abortion Care. https://web.archive.org/web/20241203153133/https://prochoice.org/providers/quality-standards/. Updated: January 1, 2024. Accessed: December 3, 2024.
  16. American College of Obstetricians and Gynecologists. Practic Bulletin No. 135: Second-trimester abortion (Reaffirmed 2023). Obstet Gynecol. 2013.doi: 10.1097/01.AOG.0000431056.79334.cc. . | Open in Read by QxMD
  17. Zwerling B, Edelman A, Jackson A, Burke A, Prabhu with the assistance of M Prabhu. Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation. Contraception. 2024; 129: p.110143.doi: 10.1016/j.contraception.2023.110143 . | Open in Read by QxMD
  18. American College of Obstetricians and Gynecologists. ACOG Clinical Practice Update: Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation. Obstet Gynecol. 2024; 144 (6): p.e140-e143.doi: 10.1097/aog.0000000000005733 . | Open in Read by QxMD
  19. Prabhu M, Louis JM, Kuller JA. Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion at less than 12 weeks of gestation. Am J Obstet Gynecol. 2024; 230 (5): p.B2-B5.doi: 10.1016/j.ajog.2024.02.288 . | Open in Read by QxMD
  20. Curtis KM, Nguyen AT, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. MMWR. Recomm Rep. 2024; 73 (3): p.1-77.doi: 10.15585/mmwr.rr7303a1 . | Open in Read by QxMD
  21. $Contributor Disclosures - Induced abortion. All of the relevant financial relationships listed for the following individuals have been mitigated: Jan Schlebes (medical editor, is a shareholder in Fresenius SE & Co KGaA). None of the other individuals in control of the content for this article reported relevant financial relationships with ineligible companies. For details, please review our full conflict of interest (COI) policy.
  22. Lyus RJ, Gianutsos P, Gold M. First Trimester Procedural Abortion in Family Medicine. J Am Board Fam Med. 2009; 22 (2): p.169-174.doi: 10.3122/jabfm.2009.02.070204 . | Open in Read by QxMD
  23. Harris LH, Grossman D. Complications of Unsafe and Self-Managed Abortion. N Engl J Med. 2020; 382 (11): p.1029-1040.doi: 10.1056/nejmra1908412 . | Open in Read by QxMD
  24. Wetterer L, Shenko C, Prine L. Medical Assessment After Self-Managed Abortion.. Am Fam Physician. 2023; 108 (5): p.519-522.
Sign up and get unlimited access.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer